FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200626896> ?p ?o ?g. }

• W4200626896 abstract "Ursolic acid is a natural pentacyclic triterpenoid that exerts a potent anticancer effect. Furthermore, it is classified as a BCS class IV compound possessing low permeability and water solubility, consequently demonstrating limited bioavailability in addition to low therapeutic effectiveness. Nanoparticles are developed to modify the physical characteristics of drug and can often be produced in the range of 30-200 nm, providing highly effective cancer therapy due to the Enhanced Permeation and Retention (EPR) Effect. This study aims to provide a review of the efficacy and safety of various types of Ursolic Acid-loading nanoparticles within the setting of preclinical and clinical anticancer studies. This literature study used scoping review method, where the extracted data must comply with the journal inclusion criteria of within years of 2010-2020. The identification stage produced 237 suitable articles. Duplicate screening was then conducted followed by the initial selection of 18 articles that had been reviewed and extracted for data analysis. Based on this review, the use of nanoparticles can be seen to increase the anticancer efficacy of Ursolic Acid in terms of several parameters including pharmacokinetic data, survival rates and inhibition rates, as well as the absence of serious toxicity in preclinical and clinical trials in terms of several parameters including body weight, blood clinical chemistry, and organ histipathology. Based on this review, the use of nanoparticles has been able to increase the anticancer efficacy of Ursolic Acid, as well as show the absence of serious toxicity in preclinical and clinical trials. Evenmore, the liposome carrier provides development data that has reached the clinical trial phase I. The use of nanoparticle provides high potential for Ursolic Acid delivery in cancer therapy." @default.
• W4200626896 created "2021-12-31" @default.
• W4200626896 creator A5000594244 @default.
• W4200626896 creator A5012430639 @default.
• W4200626896 creator A5015434187 @default.
• W4200626896 creator A5059896996 @default.
• W4200626896 date "2021-12-24" @default.
• W4200626896 modified "2023-09-25" @default.
• W4200626896 title "Nanoparticles use for Delivering Ursolic Acid in Cancer Therapy: A Scoping Review" @default.
• W4200626896 cites W1497889772 @default.
• W4200626896 cites W1804398254 @default.
• W4200626896 cites W1971723787 @default.
• W4200626896 cites W1974920077 @default.
• W4200626896 cites W1976041621 @default.
• W4200626896 cites W1989230986 @default.
• W4200626896 cites W1992972854 @default.
• W4200626896 cites W1993562925 @default.
• W4200626896 cites W2007623125 @default.
• W4200626896 cites W2009814858 @default.
• W4200626896 cites W2015930349 @default.
• W4200626896 cites W2020529586 @default.
• W4200626896 cites W2023025402 @default.
• W4200626896 cites W2024424196 @default.
• W4200626896 cites W2031524038 @default.
• W4200626896 cites W2037409959 @default.
• W4200626896 cites W2037501592 @default.
• W4200626896 cites W2044884111 @default.
• W4200626896 cites W2051925512 @default.
• W4200626896 cites W2071528876 @default.
• W4200626896 cites W2078120653 @default.
• W4200626896 cites W2078628247 @default.
• W4200626896 cites W2083349615 @default.
• W4200626896 cites W2083710155 @default.
• W4200626896 cites W2097603366 @default.
• W4200626896 cites W2100173894 @default.
• W4200626896 cites W2117228502 @default.
• W4200626896 cites W2119784812 @default.
• W4200626896 cites W2138138956 @default.
• W4200626896 cites W2142504874 @default.
• W4200626896 cites W2144200097 @default.
• W4200626896 cites W2146205672 @default.
• W4200626896 cites W2162495360 @default.
• W4200626896 cites W2187976253 @default.
• W4200626896 cites W2233813090 @default.
• W4200626896 cites W2274305540 @default.
• W4200626896 cites W2296948888 @default.
• W4200626896 cites W2299829932 @default.
• W4200626896 cites W2317275224 @default.
• W4200626896 cites W2317485478 @default.
• W4200626896 cites W2334019335 @default.
• W4200626896 cites W2338472710 @default.
• W4200626896 cites W2401094910 @default.
• W4200626896 cites W2479610589 @default.
• W4200626896 cites W2551400049 @default.
• W4200626896 cites W2555505930 @default.
• W4200626896 cites W2589732760 @default.
• W4200626896 cites W2620796872 @default.
• W4200626896 cites W2626318019 @default.
• W4200626896 cites W2753400916 @default.
• W4200626896 cites W2767248769 @default.
• W4200626896 cites W2775406340 @default.
• W4200626896 cites W2794301039 @default.
• W4200626896 cites W2799408579 @default.
• W4200626896 cites W2800904663 @default.
• W4200626896 cites W2946543510 @default.
• W4200626896 cites W2965630189 @default.
• W4200626896 cites W2970329262 @default.
• W4200626896 cites W2993584674 @default.
• W4200626896 cites W2999063177 @default.
• W4200626896 cites W2999468537 @default.
• W4200626896 cites W3002029912 @default.
• W4200626896 cites W3016050883 @default.
• W4200626896 cites W3023478404 @default.
• W4200626896 cites W3039095477 @default.
• W4200626896 cites W3049342150 @default.
• W4200626896 cites W3080627181 @default.
• W4200626896 cites W3091697907 @default.
• W4200626896 cites W3094861029 @default.
• W4200626896 cites W3109746568 @default.
• W4200626896 cites W3118608928 @default.
• W4200626896 cites W3120479995 @default.
• W4200626896 cites W786460275 @default.
• W4200626896 doi "https://doi.org/10.3389/fphar.2021.787226" @default.
• W4200626896 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35002719" @default.
• W4200626896 hasPublicationYear "2021" @default.
• W4200626896 type Work @default.
• W4200626896 citedByCount "4" @default.
• W4200626896 countsByYear W42006268962022 @default.
• W4200626896 countsByYear W42006268962023 @default.
• W4200626896 crossrefType "journal-article" @default.
• W4200626896 hasAuthorship W4200626896A5000594244 @default.
• W4200626896 hasAuthorship W4200626896A5012430639 @default.
• W4200626896 hasAuthorship W4200626896A5015434187 @default.
• W4200626896 hasAuthorship W4200626896A5059896996 @default.
• W4200626896 hasBestOaLocation W42006268961 @default.
• W4200626896 hasConcept C126322002 @default.
• W4200626896 hasConcept C181389837 @default.
• W4200626896 hasConcept C185592680 @default.
• W4200626896 hasConcept C2779513101 @default.
• W4200626896 hasConcept C2780035454 @default.

• next